We estimate that the CEO of AtaiBeckley Inc. ($ATAI), Srinivas Rao, M.D., Ph.D., received a compensation of $4,420,555 in 2025. This is an increase of 21.67% from an estimated $3,462,560 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 22, 2026. Note that parsing errors may occur.
You can track $ATAI on Quiver Quantitative's $ATAI stock dashboard.
$ATAI Stock Insider Trading Activity
$ATAI Stock insiders have traded $ATAI stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ATAI stock by insiders over the last 6 months:
- KEVIN JAMES CRAIG (Chief Medical Officer) has made 0 purchases and 2 sales selling 142,579 shares for an estimated $567,895.
- COSMO FEILDING-MELLEN sold 39,594 shares for an estimated $154,377
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ATAI Stock Hedge Fund Activity
We have seen 73 institutional investors add shares of $ATAI Stock stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 7,677,289 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $31,400,112
- DEEP TRACK CAPITAL, LP added 4,677,289 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,130,112
- BLACKROCK, INC. added 2,808,808 shares (+63836.5%) to their portfolio in Q4 2025, for an estimated $11,488,024
- FORESITE CAPITAL MANAGEMENT VI LLC added 2,750,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,247,500
- RTW INVESTMENTS, LP added 2,000,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,180,000
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,936,267 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $7,919,332
- AMERIPRISE FINANCIAL INC added 1,735,252 shares (+inf%) to their portfolio in Q4 2025, for an estimated $7,097,180
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ATAI Stock Analyst Ratings
Wall Street analysts have issued reports on $ATAI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 01/20/2026
To track analyst ratings and price targets for $ATAI Stock, check out Quiver Quantitative's $ATAI forecast page.
$ATAI Stock Price Targets
Multiple analysts have issued price targets for $ATAI recently. We have seen 6 analysts offer price targets for $ATAI in the last 6 months, with a median target of $15.5.
Here are some recent targets:
- Sumant Kulkarni from Canaccord Genuity set a target price of $15.0 on 04/20/2026
- Eddie Hickman from Guggenheim set a target price of $16.0 on 04/17/2026
- David Hoang from Deutsche Bank set a target price of $12.0 on 03/27/2026
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $25.0 on 03/17/2026
- Ami Fadia from Needham set a target price of $14.0 on 03/09/2026
- Justin Walsh from Jones Trading set a target price of $16.0 on 12/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
